logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 

Equities – Your destination to connect with the growth investment community.
ARIAD Pharmaceuticals Inc.

ARIAD Pharmaceuticals Inc. (ARIA)

Follow

Details

Wall

Profile


Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Issuer Information

Exchange: NASDAQ
Market Cap: 3651332094
CEO: Harvey J. Berger
Employees: 300
Issuer Type: CS
Auditor: Deloitte & Touche LLP
Last Audit: UQ
CIK: 884731
Sector: Healthcare
Industry: Biotechnology
Sub-Industry: Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturin (325414)
SIC: 2836
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 617 494-0400
Address: 26 Landsdowne Street
Address 2:
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139-4234
Fax:

Videos

No public videos available.

Blog

No Result Found.

News

No Result Found.

Trending

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.